Document Detail


History of clinical identification of West syndrome--in quest after the classic.
MedLine Citation:
PMID:  11720793     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The West syndrome (WS) is a distinct age-dependent global encephalopathy which encompasses manifold problems of developing brain, and because of this, WS stands out as a symbolic syndrome for child neurology as a whole. It is unanimously recognized that this syndrome was first described by Dr W.J. West of Tunbridge, UK in 1841. In the following 100 years, however, the disease remained in the dark of neglect and misconception. An extensive literature survey carried out by Gastaut et al. revealed that only a few articles followed after West; about one article per decade between 1840 and 1920, and 18 per decade between 1920-1950. Among those, most distinguished contributions were detailed clinical observations made by Asal and Moro (1925) and Zellweger (1948), according to the author's opinion. An explosion of scientific interest at the world level was triggered by the discovery of hypsarhythmia on EEG by Gibbs and Gibbs in 1952 and of dramatic therapeutic effect of ACTH by Sorel and Dusaucy-Bauloye in 1958. In Japan, Katsutaka Takagi first reported four cases of apparent WS in 1903. An extensive search for Japanese classic literatures conducted by the author revealed 13 highly probable WS cases scattered in eight papers by 1945. A great confusion in terms of a concept of the disease had been prevailed for 50 years after Takagi until 1957, when the author first reported clinical and EEG findings in 99 cases, together with a 16 mm film demonstration of typical spasms in three cases at the Japan Pediatric Society meeting. Needless to say, however, WS turned out to be one of the most popular targets for clinical investigation of child neurologists in Japan afterwards, and nowadays, about 30 to 40 reports continue to be either published or orally presented at the meeting each year.
Authors:
Y Fukuyama
Related Documents :
7482253 - Adult-onset presentation of dandy-walker variant in siblings.
2054053 - Pisa syndrome without neuroleptic exposure in a patient with dementia of the alzheimer ...
24528563 - Acute primary actinomycosis involving the hard palate of a diabetic patient.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Brain & development     Volume:  23     ISSN:  0387-7604     ISO Abbreviation:  Brain Dev.     Publication Date:  2001 Dec 
Date Detail:
Created Date:  2001-11-26     Completed Date:  2002-02-08     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7909235     Medline TA:  Brain Dev     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  779-87     Citation Subset:  IM    
Affiliation:
Child Neurology Institute, 6-12-17 Minami-Shinagawa, Shinagawa-ku, Tokyo 140-0004, Japan. yfukuyam@sc4.so-net.ne.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenocorticotropic Hormone / therapeutic use
Brain / growth & development*,  physiopathology*
Electroencephalography
Female
Humans
Infant
Infant, Newborn
Japan
Male
Spasm / etiology,  physiopathology
Spasms, Infantile / diagnosis*,  physiopathology
Chemical
Reg. No./Substance:
9002-60-2/Adrenocorticotropic Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Mechanisms for clearance of released N-acetylaspartylglutamate in crayfish nerve fibers: implication...
Next Document:  Evaluation of autonomic nervous system function with spectral analysis of heart rate variability in ...